Skip to content

IEMbase 0485: SLC37A4-related glucose-6-phosphate transporter deficiency

Scope

Field Value
IEMbase ID 485
Nosology 3.4.04.01
Gene SLC37A4
External IDs OMIM:232220; ORPHA:79259
Generated mapping CANDIDATE; medium candidate Glycogen_Storage_Disease_Type_I.yaml
Candidate DisMech targets Glycogen_Storage_Disease_Type_I.yaml#GSD Ib (glucose-6-phosphate transporter deficiency)
Review date 2026-07-07

IEMbase phenotype signal

IEMbase represents autosomal recessive SLC37A4-related glucose-6-phosphate transporter deficiency as GSD Ib / GSD I non-a. Treatments include fasting avoidance, uncooked cornstarch, granulocyte colony-stimulating factor, liver transplantation, empagliflozin, and hematopoietic stem cell transplant. Biochemical rows overlap GSD Ia for glucose/lactate/lipid/urate/liver glycogen abnormalities and add decreased neutrophil count plus increased plasma and urine 1,5-anhydroglucitol-6-phosphate. Clinical rows include anemia, leukocyte function impairment, recurrent infections, bleeding tendency, diarrhea, liver adenoma/carcinoma, renal complications, osteopenia, pancreatitis, pulmonary hypertension, short stature, tachypnea, delayed tooth eruption, and taurodontism.

DisMech phenotype coverage

Glycogen_Storage_Disease_Type_I.yaml#GSD Ib (glucose-6-phosphate transporter deficiency) is the exact local target. The entry models SLC37A4/G6PT deficiency as the GSD Ib subtype, the shared GSD I metabolic branch, and the GSD Ib-specific neutropenia / neutrophil dysfunction branch with recurrent infections, oral ulcers, mucosal lesions, and inflammatory bowel disease context. It includes uncooked cornstarch, granulocyte colony-stimulating factor, empagliflozin for GSD Ib neutropenia, liver transplantation, kidney transplantation, and other metabolic complication treatments.

Concordance and completeness

Judgement: accept generated candidate as correct subtype-level coverage.

The generated mapper treated this only as a medium disease-level candidate, but the local GSD I file has an explicit GSD Ib subtype and SLC37A4 mechanisms. The resources agree on the shared fasting hypoglycemia/metabolic GSD I phenotype, the distinguishing neutropenia/neutrophil-dysfunction arm, infection risk, cornstarch, G-CSF, empagliflozin, and liver-transplant context. IEMbase adds important enrichment prompts, especially 1,5-anhydroglucitol-6-phosphate, biotinidase, hematopoietic stem cell transplant, delayed tooth eruption, taurodontism, and some renal/hepatic complication granularity.

Curation actions

  • Resolve this row to Glycogen_Storage_Disease_Type_I.yaml#GSD Ib (glucose-6-phosphate transporter deficiency).
  • Treat broad disease-level Glycogen_Storage_Disease_Type_I.yaml as acceptable only if the subtype anchor is preserved.
  • Verify 1,5-anhydroglucitol-6-phosphate, hematopoietic stem cell transplant, biotinidase, delayed tooth eruption, and taurodontism before structural import.